BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment

    PMA: P130006 · Supplement: S014 · Decision Jan 8, 2015
    View on FDA
    Classifications
    1
    FEI Numbers
    14
    Registration Numbers
    14

    Basic Information

    Device Name
    System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment
    Trade Name
    GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
    PMA Number
    P130006
    Supplement Number
    S014
    Device Class
    FDA Class 3
    Product Code
    PFV
    Generic Name
    System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment
    Medical Specialty
    Unknown
    Advisory Committee
    Cardiovascular
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    January 8, 2015
    Date Received
    October 14, 2014
    Supplement Type
    Real-Time Process
    Supplement Reason
    Change Design/Components/Specifications/Material
    Expedited Review
    N

    Advisory Committee Statement

    APPROVAL FOR THE ADDITION OF A 7.5 CM ENDOPROSTHESIS LENGTH IN 5-8 MM AND 9 MM DIAMETER CONFIGURATIONS, WITH AND WITHOUT HEPARIN, ON BOTH THE 0.035 GUIDEWIRE CATHETER (75CM AND 120CM LENGTH) AND THE 0.014/0.018 GUIDEWIRE CATHETER (120CM LENGTH).

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    PFV System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment